taf
Showing 1 - 17 of 17
Chronic Hepatitis B Trial in Changchun (GLS4, RTV, TAF)
Completed
- Chronic Hepatitis B
- GLS4
- +2 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
May 20, 2022
Chronic Hepatitis B Trial in Auckland (TAF, TDF, Other approved antivirals)
Completed
- Chronic Hepatitis B
- TAF
- +2 more
-
Auckland, New ZealandAuckland City Hospital
Jun 7, 2022
Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)
Not yet recruiting
- Hepatitis B, Chronic
- hepalatide
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Tong Ren Hospital
Nov 12, 2021
Chronic Hepatitis B Trial in Hong Kong, Korea, Republic of (Inarigivir Soproxil, TAF)
Terminated
- Chronic Hepatitis B
- Inarigivir Soproxil
- TAF
-
Hong Kong, Hong Kong
- +12 more
Mar 8, 2022
Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)
Not yet recruiting
- Chronic Hepatitis Delta Virus Infection
- HH-003(20mg/kg)
- +2 more
- (no location specified)
May 7, 2023
HBV, Chronic HBV Infections Trial in China (TAF, TDF, TAF Placebo)
Active, not recruiting
- HBV
- Chronic HBV Infections
- TAF
- +3 more
-
Beijing, China
- +24 more
Mar 17, 2022
Chronic Hepatitis B Trial in Worldwide (TAF, Placebo)
Recruiting
- Chronic Hepatitis B
- TAF
- Placebo
-
Los Angeles, California
- +58 more
Jul 14, 2022
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)
Active, not recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Edegem, Belgium
- +12 more
Jan 17, 2023
HIV-1 Infection Trial in United States (Lenacapavir, Placebo, B/F/TAF)
HBV, Chronic HBV Infection Trial in Worldwide (TAF, TDF, TAF Placebo)
Active, not recruiting
- HBV
- Chronic HBV Infection
- TAF
- +3 more
-
Los Angeles, California
- +159 more
Mar 17, 2022
Propofol Fumarate for Mother-to-child Blocking of Hepatitis B
Unknown status
- Chronic Hepatitis B Infection
- High Viral Load
- TAF
- TDF
-
Beijing, Beijing, ChinaBeijing Ditan Hospital, Capital Medical University
Oct 19, 2019